VYNE Therapeutics(VYNE.US)

Last Updated 19:00:00 ET
longbridge loading

14:06 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN

prnewswire·
US
XHE
-0.31%
US
IXJ
+0.49%
US
ARWR
-2.31%
prnewswire·
US
XHE
-0.31%
US
IXJ
+0.49%
US
ARWR
-2.31%

VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance

Tip Ranks·
US
PBE
+0.33%
US
BIB
+0.08%
US
BBH
+0.63%
Tip Ranks·
US
PBE
+0.33%
US
BIB
+0.08%
US
BBH
+0.63%

08:42 ETSYNEVIT® Addresses Hormonal Imbalance Ahead of National Endometriosis Awareness Month

prnewswire·
US
BBH
+0.63%
US
BIB
+0.08%
US
XHE
-0.31%
prnewswire·
US
BBH
+0.63%
US
BIB
+0.08%
US
XHE
-0.31%

Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics

Tip Ranks·
US
HIND
+6.64%
US
VYNE
-0.09%
Tip Ranks·
US
HIND
+6.64%
US
VYNE
-0.09%

Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health | VYND Stock News

StockTitan·
US
IHE
+0.77%
US
SBIO
+1.57%
US
PBE
+0.33%
StockTitan·
US
IHE
+0.77%
US
SBIO
+1.57%
US
PBE
+0.33%

Investigation into VYNE Therapeutics Inc. for possible breaches of fiduciary duty in transaction with Yarrow Bioscience.

Unusual Whales·
US
VYNE
-0.09%
Unusual Whales·
US
VYNE
-0.09%

19:39 ET Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

prnewswire·
US
VYNE
-0.09%
prnewswire·
US
VYNE
-0.09%

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga_article·
US
VYNE
-0.09%
US
CUE
-7.17%
US
IXHL
-1.29%
benzinga_article·
US
VYNE
-0.09%
US
CUE
-7.17%
US
IXHL
-1.29%
© 2026 Longbridge｜Disclaimer